FOR IMMEDIATE RELEASE

(Brandon, Florida)– According to reports from The Multiple Sclerosis Foundation, an estimated 2.5 million people suffer from MS globally with 200 new cases diagnosed each week in the United States alone. Studies show Parkinson’s disease afflicts approximately 1 million across the nation with 60,000 new cases arising annually. With this surging prevalence in mind, a spokesperson for NSI Stem Cell has launched a new type of treatment for those affected by these and a number of other chronic conditions.

Said the spokesperson, “Until fairly recently, patients have found limited relief with many of the traditional treatments available to them. Science has made significant strides in stem cell therapy over the last several years, opening up an array of new opportunities for all those individuals suffering from chronic medical conditions. We’ve successfully treated a variety of issues using adipose stem cells, and we’re proud to extend our treatments to those with MS and Parkinson’s disease.”

Adipose stem cells are taken from adult fatty tissue, typically that of the abdomen or above the superior iliac spine. When compared to retrieval from bone marrow, the process of gathering adipose stem cells is considerably less invasive. Research indicates these are also up to 500 percent more potent than their counterparts. Once removed from fatty tissues, these cells are relocated to areas of the body in which they are needed.

Stem cells have been the target of numerous medical studies for more than three decades. During the early 1980’s, scientists discovered such cells held properties unlike others. Having not yet developed specific structures and functions, they have the capacity to regenerate blood as well as muscle, nerve and organ tissues. In the case of Stem cell therapy for ms, they are used to regenerate nerves as well as their protective coverings known as myelin sheaths. When combating Parkinson’s disease, stem cells are used in the reconstruction of dopamine-producing cells in the brain.

Concluded the clinic’s spokesperson, “Patients undergoing our stem cell for copd treatments have experienced greater lung capacity and a reduction of mucous and phlegm as well as improvements in other symptoms accompanying the condition. We’re also treating diabetes, ALS, back and joint problems, neuropathy, spinal cord injuries and a range of other issues thanks to breakthroughs in the medical community. Research is ongoing, and we will continue to offer new therapies as they become available. We’re proud to offer these services to patients and eagerly await future advancements.”

About NSI Stem Cell:

NSI Stem Cell is a stem cell therapy center and clinic with four locations throughout Florida. Using revolutionary procedures, their team successfully treats patients with chronic and debilitating conditions who have found little relief through other methods.

Source: http://markets.financialcontent.com/ms.intelvalue/news/read/33351941

NSI Stem Cell Launches New Multiple Sclerosis and Parkinson’s Disease Treatments